Identifying Factors of Microparticles Modified with Arginine Derivatives That Induce Phenotypic Shifts in Macrophages

ACS Biomaterials Science and Engineering

Volumn 2, Issue 6, 2016, Pages 946-953

  Dunn Sale, Alexander J ^a   Bratlie, Kaitlin M ^a,b  

^a Iowa State University of Science and Technology   (United States)

^b IOWA STATE UNIVERSITY   (United States)

Author keywords

macrophage phenotypes; polymer properties; TNF

Indexed keywords

ARGINASE; ARGININE DERIVATIVE; CARBOXYLIC ACID; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; NITRITE; POLY( N ISOPROPYLACRYLAMIDE CO ACRYLIC ACID); POLYMER; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UREA;

ANIMAL CELL; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; DRUG DELIVERY SYSTEM; ENZYME ACTIVITY; MACROPHAGE CULTURE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; ZETA POTENTIAL;

EID: 85006218256     PISSN: None     EISSN: 23739878     Source Type: Journal    
DOI: 10.1021/acsbiomaterials.6b00041     Document Type: Article

References (51)

1. Acharya, A. P.; Dolgova, N. V.; Clare-Salzler, M. J.; Keselowsky, B. G. Adhesive substrate-modulation of adaptive immune responses Biomaterials 2008, 29, 4736-50 10.1016/j.biomaterials.2008.08.040
2. Schutte, R. J.; Xie, L.; Klitzman, B.; Reichert, W. M. In vivo cytokine-associated responses to biomaterials Biomaterials 2009, 30, 160-8 10.1016/j.biomaterials.2008.09.026
3. Anderson, J. M.; Rodriguez, A.; Chang, D. T. Foreign body reaction to biomaterials Semin. Immunol. 2008, 20, 86-100 10.1016/j.smim.2007.11.004
4. Nilsson, B.; Ekdahl, K. N.; Mollnes, T. E.; Lambris, J. D. The role of complement in biomaterial-induced inflammation Mol. Immunol. 2007, 44, 82-94 10.1016/j.molimm.2006.06.020
5. Wang, D.; Phan, N.; Isely, C.; Bruene, L.; Bratlie, K. M. The effect of polymer chemistry and macrophage phenotype on particle internalization Biomacromolecules 2014, 15, 4102-10 10.1021/bm5011382
6. Wang, D.; Bratlie, K. M. Influence of Polymer Chemistry on Cytokine Secretion from Polarized Macrophages ACS Biomater. Sci. Eng. 2015, 1, 166-74 10.1021/ab5001063
7. Bygd, H. C.; Akilbekova, D.; Munioz, A.; Forsmark, K. D.; Bratlie, K. M. Poly-l-arginine based materials as instructive substrates for fibroblast synthesis of collagen Biomaterials 2015, 63, 47-57 10.1016/j.biomaterials.2015.05.045
8. Bygd, H. C.; Forsmark, K. D.; Bratlie, K. M. Altering in vivo macrophage responses with modified polymer properties Biomaterials 2015, 56, 187-97 10.1016/j.biomaterials.2015.03.042
9. Petersen, L. K.; Xue, L.; Wannemuehler, M. J.; Rajan, K.; Narasimhan, B. The simultaneous effect of polymer chemistry and device geometry on the in vitro activation of murine dendritic cells Biomaterials 2009, 30, 5131-42 10.1016/j.biomaterials.2009.05.069
10. Ariganello, M. B.; Simionescu, D. T.; Labow, R. S.; Lee, J. M. Macrophage differentiation and polarization on a decellularized pericardial biomaterial Biomaterials 2011, 32, 439-49 10.1016/j.biomaterials.2010.09.004
11. Rodriguez, A.; Meyerson, H.; Anderson, J. M. Quantitative in vivo cytokine analysis at synthetic biomaterial implant sites J. Biomed. Mater. Res.; Part A 2008, 89, 152-9 10.1002/jbm.a.31939
12. Mosser, D. M. The many faces of macrophage activation J. Leukocyte Biol. 2003, 73, 209-12 10.1189/jlb.0602325
13. Murray, P. J.; Allen, J. E.; Biswas, S. K.; Fisher, E. A.; Gilroy, D. W.; Goerdt, S. et al. Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines Immunity 2014, 41, 14-20 10.1016/j.immuni.2014.06.008
14. Mantovani, A.; Locati, M. Tumor-associated macrophages as a paradigm of macrophage plasticity, diversity, and polarization: lessons and open questions Arterioscler.; Thromb.; Vasc. Biol. 2013, 33, 1478-83 10.1161/ATVBAHA.113.300168
15. Biswas, S. K.; Sica, A.; Lewis, C. E. Plasticity of Macrophage Function during Tumor Progression: Regulation by Distinct Molecular Mechanisms J. Immunol. 2008, 180, 2011-7 10.4049/jimmunol.180.4.2011
16. Qian, B.-Z.; Pollard, J. W. Macrophage diversity enhances tumor progression and metastasis Cell 2010, 141, 39-51 10.1016/j.cell.2010.03.014
17. Gollob, J A.; Mier, J. W.; Veenstra, K.; McDermott, D. F.; Clancy, D.; Clancy, M. et al. Phase I trial of twice-weekly intravenous interleukin 12 in patients with metastatic renal cell cancer or malignant melanoma: ability to maintain IFN-gamma induction is associated with clinical response Clin. Cancer Res. 2000, 6, 1678-92
18. Hill, H.; Conway, T.; Sabel, M.; Jong, Y.; Mathiowitz, E.; Bankert, R. et al. Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity and cure of disseminated disease Cancer Res. 2002, 62, 7254-63
19. Watkins, S. K.; Egilmez, N. K.; Suttles, J.; Stout, R. D. IL-12 rapidly alters the functional profile of tumor-associated and tumor-inflitrating macrophages in vitro and in vivo J. Immunol. 2007, 178, 1357-62 10.4049/jimmunol.178.3.1357
20. Hofkens, W.; Schelbergen, R.; Storm, G.; van den Berg, W. B.; van Lent, P. L. Liposomal Targeting of Prednisolone Phosphate to Synovial Lining Macrophages during Experimental Arthritis Inhibits M1 Activation but Does Not Favor M2 Differentiation PLoS One 2013, 8, e54016 10.1371/journal.pone.0054016
21. Jain, S.; Tran, T.-H.; Amiji, M. Macrophage repolarization with targeted alginate nanoparticles containing IL-10 plasmid DNA for the treatment of experimental arthritis Biomaterials 2015, 61, 162-77 10.1016/j.biomaterials.2015.05.028
22. Bronte, V.; Zanovello, P. Regulation of immune responses by L-arginine metabolism Nat. Rev. Immunol. 2005, 5, 641-54 10.1038/nri1668
23. Morris, S. M. Arginine metabolism: boundaries of our knowledge J. Nutr. 2007, 137, 1602S-1609S
24. Mantovani, A.; Sica, A.; Sozzani, S.; Allavena, P.; Vecchi, A.; Locati, M. The chemokine system in diverse forms of macrophage activation and polarization Trends Immunol. 2004, 25, 677-86 10.1016/j.it.2004.09.015
25. Lumeng, C. N.; Bodzin, J. L.; Saltiel, A. R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization J. Clin. Invest. 2007, 117, 175-84 10.1172/JCI29881
26. Allen, J. E.; Loke, P. Divergent roles for macrophages in lymphatic filariasis Parasite Immunol. 2001, 23, 345-52 10.1046/j.1365-3024.2001.00394.x
27. Murphy, B. S.; Sundareshan, V.; Cory, T. J.; Hayes, D.; Anstead, M. I.; Feola, D. J. Azithromycin alters macrophage phenotype J. Antimicrob. Chemother. 2008, 61, 554-60 10.1093/jac/dkn007
28. Rath, M.; Muller, I.; Kropf, P.; Closs, E. I.; Munder, M. Metabolism via Arginase or Nitric Oxide Synthase: Two Competing Arginine Pathways in Macrophages Front. Immunol. 2014, 5, 1-10 10.3389/fimmu.2014.00532
29. Amat di San Filippo, C.; Taylor, M. R. G.; Mestroni, L.; Botto, L. D.; Longo, N. Cardiomyopathy and carnitine deficiency Mol. Genet. Metab. 2008, 94, 162-6 10.1016/j.ymgme.2008.02.002
30. Ferrante, R.; Andreassen, O.; Jenkins, B.; Dedeoglu, a; Kuemmerle, S.; Kubilus, J. et al. Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease J. Neurosci. 2000, 20, 4389-97
31. GUALANO, B.; DE SALLES PAINNELI, V.; ROSCHEL, H.; ARTIOLI, G. G.; NEVES, M.; DE Sá PINTO, A. L. et al. Creatine in Type 2 Diabetes Med. Sci. Sports Exercise 2011, 43, 770-8 10.1249/MSS.0b013e3181fcee7d
32. Arimoto, T.; Bing, G. Up-regulation of inducible nitric oxide synthase in the substantia nigra by lipopolysaccharide causes microglial activation and neurodegeneration Neurobiol. Dis. 2003, 12, 35-45 10.1016/S0969-9961(02)00017-7
33. Grant, S. K.; Green, B. G.; Stiffey-Wilusz, J.; Durette, P. L.; Shah, S. K.; Kozarich, J. W. Structural requirements for human inducible nitric oxide synthase substrates and substrate analogue inhibitors Biochemistry 1998, 37, 4174-80 10.1021/bi972481d
34. Jang, J. J.; Ho, H. K.; Kwan, H. H.; Fajardo, L. F.; Cooke, J. P. Angiogenesis is impaired by hypercholesterolemia: role of asymmetric dimethylarginine Circulation 2000, 102, 1414-9 10.1161/01.CIR.102.12.1414
35. Koc, a; Ozkan, T.; Karabay, a Z; Sunguroglu, a; Aktan, F. Effect of L-carnitine on the synthesis of nitric oxide in RAW 264·7 murine macrophage cell line Cell Biochem Funct 2011, 29, 679-85 10.1002/cbf.1807
36. Oudman, I.; Clark, J. F.; Brewster, L. M. The Effect of the Creatine Analogue Beta-guanidinopropionic Acid on Energy Metabolism: A Systematic Review PLoS One 2013, 8, e52879 10.1371/journal.pone.0052879
37. Hagen, T. M.; Ingersoll, R. T.; Wehr, C. M.; Lykkesfeldt, J.; Vinarsky, V.; Bartholomew, J. C. et al. Acetyl-L-carnitine fed to old rats partially restores mitochondrial function and ambulatory activity Proc. Natl. Acad. Sci. U. S. A. 1998, 95, 9562-6 10.1073/pnas.95.16.9562
38. Calabrese, V.; Scapagnini, G.; Ravagna, a.; Bella, R.; Butterfield, D a.; Calvani, M. et al. Disruption of Thiol Homeostasis and Nitrosative Stress in the Cerebrospinal Fluid of Patients with Active Multiple Sclerosis: Evidence for a Protective Role of Acetylcarnitine Neurochem. Res. 2003, 28, 1321-8 10.1023/A:1024984013069
39. Ricote, M.; Li, A. C.; Willson, T. M.; Kelly, C. J.; Glass, C. K. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation Nature 1998, 391, 79-82 10.1038/34178
40. Guastadisegni, C.; Minghetti, L.; Nicolini, A.; Polazzi, E.; Ade, P.; Balduzzi, M. et al. Prostaglandin E2 synthesis is differentially affected by reactive nitrogen intermediates in cultured rat microglia and RAW 264.7 cells FEBS Lett. 1997, 413, 314-8 10.1016/S0014-5793(97)00925-3
41. Motrán, C. C.; Díaz, F. L.; Gruppi, A.; Slavin, D.; Chatton, B.; Bocco, J. L. Human pregnancy-specific glycoprotein 1a (PSG1a) induces alternative activation in human and mouse monocytes and suppresses the accessory cell-dependent T cell proliferation J. Leukocyte Biol. 2002, 72, 512-21
42. Levinson, S. S. Kinetic centrifugal analyzer and manual determination of serum urea nitrogen, with use of o-phthaldialdehyde reagent Clin. Chem. 1978, 24, 2199-202
43. Bicerano, J. Prediction of Polymer Properties; Marcel Dekker Inc.: New York, 2002.
44. Rath, M.; Muller, I.; Kropf, P.; Closs, E. I.; Munder, M. Metabolism via Arginase or Nitric Oxide Synthase: Two Competing Arginine Pathways in Macrophages Front. Immunol. 2014, 5, 1-10 10.3389/fimmu.2014.00532
45. Manner, C. K.; Nicholson, B.; MacLeod, C. L. CAT2 arginine transporter deficiency significantly reduces iNOS-mediated NO production in astrocytes J. Neurochem. 2003, 85, 476-82 10.1046/j.1471-4159.2003.01695.x
46. Akilbekova, D.; Philiph, R.; Graham, A.; Bratlie, K. M. Macrophage reprogramming: influence of latex beads with various functional groups on macrophage phenotype and phagocytic uptake in vitro J. Biomed. Mater. Res.; Part A 2015, 103, 262 10.1002/jbm.a.35169
47. Barth, K a.; Waterfield, J. D.; Brunette, D. M. The effect of surface roughness on RAW 264.7 macrophage phenotype J. Biomed. Mater. Res.; Part A 2013, 101, 2679-88 10.1002/jbm.a.34562
48. Varin, A.; Mukhopadhyay, S.; Herbein, G.; Gordon, S. Alternative activation of macrophages by IL-4 impairs phagocytosis of pathogens but potentiates microbial-induced signalling and cytokine secretion Blood 2010, 115, 353-62 10.1182/blood-2009-08-236711
49. Docke, F. R. W.; Bundschuhrt, D. S.; Hartung, T.; Wendel, A.; Volk, H. In vitro prevention and reversal of lipopolysaccharide desensitization by IFN-gamma, IL-12, and granulocyte-macrophage colony-stimulating factor J. Immunol. 1997, 158, 2911-8
50. Bogdan, C.; Vodovotz, Y.; Nathan, C. Macrophage deactivation by interleukin 10 J. Exp. Med. 1991, 174, 1549-55 10.1084/jem.174.6.1549
51. Seong, S.-Y.; Matzinger, P. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses Nat. Rev. Immunol. 2004, 4, 469-78 10.1038/nri1372